Bad mood, negative emotions make you distrustful, finds study

Agencies
November 17, 2019

New Delhi, Nov 17: While having a bad mood is nothing new and can be experienced anytime, it can make you more distrustful, says a study.

Negative emotions reduce how much we trust others, even if these emotions were triggered by events that have nothing to do with the decision to trust.

Moreover, these emotions can influence the way we interact with others is well known - just think of how easily an argument with a loved one can get heated.

But what about when these emotions are triggered by events that have nothing to do with the person we are interacting with, for instance, the annoyance caused by a traffic jam or a parking fine.

Researchers call these types of emotions "incidental" because they were triggered by events that are unrelated to our currently ongoing social interactions.

It has been shown that incidental emotions frequently occur in our day-to-day interactions with others, although we might not be fully aware of them.

As part of the study, a team of researchers investigated whether the incidental aversive effect can influence the trust behaviour and the brain networks relevant for supporting social cognition.

To induce a prolonged state of negative affect, the team used the well-established threat-of-shock method, in which participants are threatened with (but only sometimes given) an unpleasant electrical shock. This threat has been shown to reliably induce anticipatory anxiety.

Within this emotional context, participants were then asked to play a trust game, which involved decisions about how much money they wished to invest in a stranger (with the stranger having the possibility to repay in kind or keep all the invested money to themselves).

The researchers have found that participants indeed trusted significantly less when they were anxious about receiving a shock, even though the threat had nothing to do with their decision to trust.

The team also recorded participants' brain responses using functional magnetic resonance imaging (MRI) while they made trust decisions. This revealed that a region that is widely implicated in understanding others' beliefs, the temporoparietal junction (TPJ), was significantly suppressed during trust decisions when participants felt threatened, but not when they felt safe.

The connectivity between the TPJ and the amygdala was also significantly suppressed by negative affect. Moreover, under safe conditions, the strength of the connectivity between the TPJ and other important social cognition regions, such as the posterior superior temporal sulcus and the dorsomedial prefrontal cortex, predicted how much participants trusted others. This relationship between brain activity and behaviour was nullified when participants felt anxious.

"These results show that negative emotions can significantly impact our social interactions, and specifically how much we trust others. They also reveal the underlying effects of a negative effect on brain circuitry. Negative effect suppresses the social cognitive neural machinery important for understanding and predicting others' behaviour," explained authors Jan Engelmann and Christian Ruff. 

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
July 2,2020

London, Jul 2: The World Health Organisation says smoking is linked to a higher risk of severe illness and death from the coronavirus in hospitalised patients, although it was unable to specify exactly how much greater those risks might be.

In a scientific brief published this week, the U.N. health agency reviewed 34 published studies on the association between smoking and Covid-19, including the probability of infection, hospitalisation, severity of disease and death.

WHO noted that smokers represent up to 18% of hospitalised coronavirus patients and that there appeared to be a significant link between whether or not patients smoked and the severity of disease they suffered, the type of hospital interventions required and patients' risk of dying.

In April, French researchers released a small study suggesting smokers were at less risk of catching Covid-19 and planned to test nicotine patches on patients and health workers — but their findings were questioned by many scientists at the time who cited the lack of definitive data.

WHO says "the available evidence suggests that smoking is associated with increased severity of disease and death in hospitalized Covid-19 patients. It recommends that smokers quit.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
June 24,2020

New Delhi, Jun 24: Expanding the testing criterion for coronavirus, the Indian Council of Medical Research has said it should be made widely available to all symptomatic individuals across the country.

"Since test, track and treat' is the only way to prevent spread of infection and save lives, it is imperative that testing should be made widely available to all symptomatic individuals in every part of the country and contact tracing mechanisms for containment of infection are further strengthened," it said in an advisory on 'Newer Additional Strategies for COVID-19 Testing' on Tuesday.

In its revised testing strategy for COVID-19 issued on May 18, the Indian Council of Medical Research (ICMR) had advised testing for all symptomatic Influenza-like illness (ILI) among returnees and migrants within seven days of illness.

All hospitalised patients who develop ILI symptoms, symptomatic individuals living within hotspots or containment zones and healthcare and frontline workers involved in containment and mitigation of coronavirus were also advised testing.

The apex health research body has also advised authorities to enable all government and private hospitals, offices and public sector units to perform antibody-based COVID-19 testing for surveillance to help allay fears and anxiety of healthcare workers and office employees.

The earlier advisories on rapid antibody testing advisories had focused on areas reporting clusters (containment zones), large migration gatherings/evacuees centers and testing of symptomatic ILI individuals at facility level.

Besides, the ICMR on Tuesday also recommended deployment of rapid antigen detection tests for COVID-19 in combination with RT-PCR tests in all containment zones, all central and state government medical colleges and government hospitals, all private hospitals approved by the National Accreditation Board for Hospitals and Healthcare (NABH), all NABL-accredited and ICMR approved private labs, for COVID-19 testing.

All hospitals, laboratories and state governments intending to perform the point-of-care antigen tests need to register with ICMR to obtain the login credentials for data entry.

"ICMR advises all state governments, public and private institutions concerned to take required steps to scale up testing for COVID-19 by deploying combination of various tests as advised," the advisory added.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
February 23,2020

Los Angeles, Feb 23: According to researchers, if administered quickly, a common medication that reduces bleeding could be a treatment for bleeding stroke.

The Spot Sign and Tranexamic Acid on Preventing ICH Growth - Australasia Trial (STOP-AUST) was a multicenter, prospective, randomized, double-blind, placebo-controlled, phase 2 clinical trial using the antifibrinolytic agent tranexamic acid in people with intracerebral hemorrhage (ICH).

ICH is a severe form of acute stroke with few treatment options.

Tranexamic acid is currently used to treat or prevent excessive blood loss from trauma, surgery, tooth removal, nosebleeds and heavy menstruation. For this study, one hundred patients with active brain bleeding were given either intravenous tranexamic acid or placebo within 4.5 hours of symptom onset.

Researchers analyzed brain CT scans taken during the 24-hour period after treatment with tranexamic acid or placebo.

Researchers found a trend towards reduced hemorrhage expansion in the group treated with tranexamic acid, especially in those treated within 3 hours of the brain bleed. However, this trend was not statistically significant. The finding was consistent with previous research using the medication.

"Further trials using tranexamic acid are ongoing and focusing on ultra-early treatment - within 2 hours. 

This is where the greatest opportunity for intervention appears to be. Tranexamic acid is inexpensive, safe and widely available. Our results and others provide great impetus for further, focused research using this treatment," Nawaf Yassi said.

Larger trials focused on patient outcomes are required for this therapy to enter routine clinical practice.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.